Owl Rock Capital Company (ORCC) got here out with quarterly earnings of $0.30 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.34 per share a 12 months in the past. These figures are adjusted for non-recurring objects.
This quarterly report represents an earnings shock of three.45%. 1 / 4 in the past, it was anticipated that this firm would submit earnings of $0.29 per share when it really produced earnings of $0.26, delivering a shock of -10.34%.
During the last 4 quarters, the corporate has surpassed consensus EPS estimates two occasions.
Owl Rock Capital Company, which belongs to the Zacks Monetary – Miscellaneous Providers business, posted revenues of $249.02 million for the quarter ended June 2021, surpassing the Zacks Consensus Estimate by 4.65%. This compares to year-ago revenues of $190.24 million. The corporate has topped consensus income estimates two occasions over the past 4 quarters.
The sustainability of the inventory’s rapid value motion primarily based on the recently-released numbers and future earnings expectations will largely rely on administration’s commentary on the earnings name.
Owl Rock Capital Company shares have added about 14.1% because the starting of the 12 months versus the S&P 500’s acquire of 17.8%.
What’s Subsequent for Owl Rock Capital Company?
Whereas Owl Rock Capital Company has underperformed the market thus far this 12 months, the query that involves traders’ minds is: what’s subsequent for the inventory?
There are not any straightforward solutions to this key query, however one dependable measure that may assist traders handle that is the corporate’s earnings outlook. Not solely does this embody present consensus earnings expectations for the approaching quarter(s), but in addition how these expectations have modified recently.
Empirical analysis reveals a robust correlation between near-term inventory actions and traits in earnings estimate revisions. Buyers can observe such revisions by themselves or depend on a tried-and-tested score device just like the Zacks Rank, which has a formidable observe report of harnessing the ability of earnings estimate revisions.
Forward of this earnings launch, the estimate revisions development for Owl Rock Capital Company was blended. Whereas the magnitude and path of estimate revisions might change following the corporate’s just-released earnings report, the present standing interprets right into a Zacks Rank #3 (Maintain) for the inventory. So, the shares are anticipated to carry out in keeping with the market within the close to future. You possibly can see the whole record of right now’s Zacks #1 Rank (Sturdy Purchase) shares right here.
It is going to be fascinating to see how estimates for the approaching quarters and present fiscal 12 months change within the days forward. The present consensus EPS estimate is $0.31 on $248.98 million in revenues for the approaching quarter and $1.17 on $962.71 million in revenues for the present fiscal 12 months.
Buyers must be aware of the truth that the outlook for the business can have a fabric affect on the efficiency of the inventory as nicely. When it comes to the Zacks Business Rank, Monetary – Miscellaneous Providers is at the moment within the prime 44% of the 250 plus Zacks industries. Our analysis reveals that the highest 50% of the Zacks-ranked industries outperform the underside 50% by an element of greater than 2 to 1.
Breakout Biotech Shares with Triple-Digit Revenue Potential
The biotech sector is projected to surge past $775 billion by 2024 as scientists develop therapies for hundreds of ailments. They’re additionally discovering methods to edit the human genome to actually erase our vulnerability to those ailments.
Zacks has simply launched Century of Biology: 7 Biotech Shares to Purchase Proper Now to assist traders revenue from 7 shares poised for outperformance. Our current biotech suggestions have produced good points of +50%, +83% and +164% in as little as 2 months. The shares on this report might carry out even higher.
See these 7 breakthrough shares now>>
Click on to get this free report
Owl Rock Capital Company (ORCC): Free Inventory Evaluation Report
To learn this text on Zacks.com click on right here.
Zacks Funding Analysis
The views and opinions expressed herein are the views and opinions of the writer and don’t essentially replicate these of Nasdaq, Inc.